Lyons-Williams Lori Insider Trades

Insider Trading History

Track insider trading activity for Lyons-Williams Lori. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Contineum Therapeutics
Contineum Therapeutics CTNM
Director
Holding Value $277k 19,000 shares
Last Trade
Jun 26, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$270k 19,000 shares
$14.19
$14.57
RAPT Therapeutics
RAPT Therapeutics RAPT
Director
Holding Value $0 0 shares
Last Trade
Mar 03, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$163k 2,813 shares
$58.02
$58.00
RAPT Therapeutics
RAPT Therapeutics RAPT
Director
Holding Value $0 0 shares
Last Trade
Mar 03, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$265k 4,561 shares
$58.02
$58.00
RAPT Therapeutics
RAPT Therapeutics RAPT
Director
Holding Value $0 0 shares
Last Trade
Mar 03, 2026 Sale (Tender)Reported as Tender on SEC Form 4.
$288k 4,956 shares
$58.02
$58.00
RAPT Therapeutics
RAPT Therapeutics RAPT
Director
Holding Value $0 0 shares
Last Trade
Mar 03, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$61.7k 1,063 shares
$58.02
$58.00
RAPT Therapeutics
RAPT Therapeutics RAPT
Director
Holding Value $0 0 shares
Last Trade
Mar 03, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$1.87M 32,229 shares
$58.02
$58.00
RAPT Therapeutics
RAPT Therapeutics RAPT
Director
Holding Value $0 0 shares
Last Trade
Mar 03, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$93.9k 1,618 shares
$58.02
$58.00
RAPT Therapeutics
RAPT Therapeutics RAPT
Director
Holding Value $287k 4,956 shares
Last Trade
Jan 30, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$286k 4,956 shares
$57.68
$58.00
Contineum Therapeutics
Contineum Therapeutics CTNM
Director
Holding Value $215k 14,750 shares
Last Trade
Jun 26, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$59.1k 14,750 shares
$4.01
$14.57
RAPT Therapeutics
RAPT Therapeutics RAPT
Director
Holding Value $15M 257,832 shares
Last Trade
May 29, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.92M 257,832 shares
$7.44
$58.00
RAPT Therapeutics
RAPT Therapeutics RAPT
Director
Holding Value $2.12M 36,490 shares
Last Trade
May 22, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.35M 36,490 shares
$37.04
$58.00
RAPT Therapeutics
RAPT Therapeutics RAPT
Director
Holding Value $751k 12,940 shares
Last Trade
May 24, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.17M 12,940 shares
$167.44
$58.00
RAPT Therapeutics
RAPT Therapeutics RAPT
Director
Holding Value $493k 8,500 shares
Last Trade
May 25, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$928k 8,500 shares
$109.12
$58.00
RAPT Therapeutics
RAPT Therapeutics RAPT
Director
Holding Value $1.31M 22,500 shares
Last Trade
Nov 09, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.89M 22,500 shares
$306.24
$58.00
RAPT Therapeutics
RAPT Therapeutics RAPT
Director
Holding Value $0 0 shares
Last Trade
Nov 09, 2021 Sale
$551k 1,800 shares
$306.24
$58.00
Five Prime Therapeutics
Five Prime Therapeutics FPRX
Director
Holding Value $0 0 shares
Last Trade
Apr 16, 2021 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$950k 25,000 shares
$38.00
$38.00
Five Prime Therapeutics
Five Prime Therapeutics FPRX
Director
Holding Value $760k 20,000 shares
Last Trade
May 14, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$82.8k 20,000 shares
$4.14
$38.00
Journey Medical
Journey Medical DERM
Chief Commercial Officer
Holding Value $0 0 shares
Last Trade
Feb 20, 2020 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
No data
No data
$7.12
Journey Medical
Journey Medical DERM
Chief Commercial Officer
Holding Value $0 0 shares
Last Trade
Feb 20, 2020 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
No data
No data
$7.12
Journey Medical
Journey Medical DERM
Chief Commercial Officer
Holding Value $0 0 shares
Last Trade
Feb 20, 2020 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
No data
No data
$7.12

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up